// App-Quantinova.ai

: Markers of eosinophilic inflammation are associated with response to the DP2 antagonist GB001 in patients with mild atopic asthma

Researchers

Presenter

  • Hector Ortega

Principal Investigators

  • Mary Fitzgerald

  • Kartik Raghupathi

  • Cindyann Tompinks

  • Dave Singh

Medical Centers

  • Gossamer Bio, Inc., San Diego, CA, United States of America

  • Pieris Pharmaceuticals, Boston, United States of America

  • University of Manchester, Manchester, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved